We are live on ! Find out more
IH

iHuman

10 hedge funds and large institutions have $5.91M invested in iHuman in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

11% more funds holding

Funds holding: 910 (+1)

2.07% less ownership

Funds ownership: 4.42%2.35% (-2.1%)

76% less capital invested

Capital invested by funds: $24.4M → $5.91M (-$18.5M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 6

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change

IH Hedge Fund Activity: Q3 2021 in Review

10 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q3 2021, worth a combined $5.91M — down 76% from $24.4M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IH positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 6 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $145K. The largest seller was Credit Suisse, cutting an estimated $6.96M.

  • 10 institutional investors held iHuman (IH) as of Q3 2021, up from 9 in Q2 2021.
  • Funds reported $5.91M of iHuman stock for Q3 2021, down 76% quarter-over-quarter.
  • 4 funds opened new iHuman positions in Q3 2021 and 3 closed out, a net change of +1 holder.
  • The largest iHuman buyer in Q3 2021 was Renaissance Technologies, an estimated $145K added.
  • The largest iHuman seller in Q3 2021 was Credit Suisse, an estimated $6.96M sold.

Based on aggregated 13F filings for Q3 2021.